OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 74 filers reported holding OCULAR THERAPEUTIX INC in Q2 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $117,000 | +387.5% | 17,167 | +563.1% | 0.00% | – |
Q1 2024 | $24,000 | -77.6% | 2,589 | -89.3% | 0.00% | – |
Q4 2023 | $107,000 | -80.0% | 24,092 | -85.8% | 0.00% | – |
Q3 2023 | $534,000 | -37.3% | 169,772 | +2.9% | 0.00% | – |
Q2 2023 | $852,000 | -12.3% | 165,055 | -10.4% | 0.00% | – |
Q1 2023 | $971,000 | +3634.6% | 184,312 | +1867.0% | 0.00% | – |
Q4 2022 | $26,000 | +18.2% | 9,370 | +78.9% | 0.00% | – |
Q3 2022 | $22,000 | +450.0% | 5,238 | +460.8% | 0.00% | – |
Q2 2022 | $4,000 | -98.8% | 934 | -98.6% | 0.00% | – |
Q1 2022 | $339,000 | -45.5% | 68,543 | -23.1% | 0.00% | – |
Q4 2021 | $622,000 | -23.4% | 89,171 | +9.7% | 0.00% | – |
Q3 2021 | $812,000 | -26.6% | 81,277 | +4.2% | 0.00% | – |
Q2 2021 | $1,106,000 | -15.5% | 77,995 | -2.1% | 0.00% | – |
Q1 2021 | $1,309,000 | -26.3% | 79,702 | -7.1% | 0.00% | -100.0% |
Q4 2020 | $1,775,000 | +151.4% | 85,782 | -7.6% | 0.00% | – |
Q3 2020 | $706,000 | -30.9% | 92,794 | -24.3% | 0.00% | – |
Q2 2020 | $1,021,000 | +58.0% | 122,546 | -6.1% | 0.00% | – |
Q1 2020 | $646,000 | +6.6% | 130,522 | -15.0% | 0.00% | – |
Q4 2019 | $606,000 | +28.4% | 153,480 | -1.2% | 0.00% | – |
Q3 2019 | $472,000 | -27.2% | 155,281 | +5.3% | 0.00% | – |
Q2 2019 | $648,000 | +50.7% | 147,478 | +36.2% | 0.00% | – |
Q1 2019 | $430,000 | -13.3% | 108,260 | -13.1% | 0.00% | – |
Q4 2018 | $496,000 | -29.1% | 124,635 | +22.6% | 0.00% | – |
Q3 2018 | $700,000 | +21.1% | 101,650 | +18.8% | 0.00% | – |
Q2 2018 | $578,000 | +8.4% | 85,573 | +4.5% | 0.00% | – |
Q1 2018 | $533,000 | +43.7% | 81,874 | -1.8% | 0.00% | – |
Q4 2017 | $371,000 | -63.4% | 83,383 | -49.2% | 0.00% | – |
Q3 2017 | $1,014,000 | -46.3% | 164,061 | -19.4% | 0.00% | -100.0% |
Q2 2017 | $1,887,000 | +2.8% | 203,558 | +3.0% | 0.00% | 0.0% |
Q1 2017 | $1,835,000 | +26.5% | 197,705 | +14.0% | 0.00% | 0.0% |
Q4 2016 | $1,451,000 | +121.5% | 173,374 | +81.7% | 0.00% | – |
Q3 2016 | $655,000 | +168.4% | 95,415 | +93.9% | 0.00% | – |
Q2 2016 | $244,000 | +741.4% | 49,210 | +1534.9% | 0.00% | – |
Q1 2016 | $29,000 | +11.5% | 3,010 | +8.8% | 0.00% | – |
Q4 2015 | $26,000 | -45.8% | 2,767 | -19.3% | 0.00% | – |
Q3 2015 | $48,000 | +20.0% | 3,429 | +80.4% | 0.00% | – |
Q2 2015 | $40,000 | +122.2% | 1,901 | +341.1% | 0.00% | – |
Q1 2015 | $18,000 | +5.9% | 431 | -41.7% | 0.00% | – |
Q4 2014 | $17,000 | -69.1% | 739 | -79.8% | 0.00% | – |
Q3 2014 | $55,000 | – | 3,650 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 3,784,850 | $15,064,000 | 62.56% |
Versant Venture Management, LLC | 2,215,384 | $8,817,228,000 | 4.36% |
SV Health Investors, LLC | 628,236 | $2,500,000 | 1.54% |
DELTEC ASSET MANAGEMENT LLC | 724,747 | $2,885,000 | 0.80% |
Endurant Capital Management LP | 232,727 | $926,000 | 0.49% |
NOTTINGHAM ADVISORS, INC. | 146,946 | $1,011,000 | 0.15% |
JGP Global Gestao de Recursos Ltda. | 12,568 | $50,000 | 0.06% |
Man Group plc | 1,187,508 | $4,726,000 | 0.02% |
Dynamic Technology Lab Private Ltd | 21,077 | $84,000 | 0.02% |
NewEdge Advisors, LLC | 36,250 | $144,000 | 0.01% |